Trials / Unknown
UnknownNCT03710616
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
A Real-world Study to Explore Recurrence/Metastases of the Early-stage (I-IIIA) NSCLC Patients and the Impact Factors of Patient Survivals
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (estimated)
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The real-world study was designed to explore recurrence/metastases of the patients with non-small cell lung cancer as measured by patient survivals and the impact factors of patient survivals.
Detailed description
The trial was designed as a real-world observational study to recruit those patients with pathologically diagnosed early-phase non-small cell lung cancer (NSCLC) who were enrolled in the clinical form 2009 to 2017 and explore recurrence/metastases of the NSCLC patients as measured by patient survivals and the impact factors of patient survivals. The study data on patient demographic characteristics, tumor biological characteristics, and clinicla treatments were collected via a retrospectively review method for evaluation of patient survivals and the relevance of clinical characteristics of the patients and patient survivals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Surgeries | Surgical operations plus systematic lymphadenectomies |
Timeline
- Start date
- 2018-03-24
- Primary completion
- 2022-12-30
- Completion
- 2023-01-01
- First posted
- 2018-10-18
- Last updated
- 2019-08-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03710616. Inclusion in this directory is not an endorsement.